These data correlate with the observation that injection of PACAP-producing stem cells, 3 days after permanent focal ischemia, do not reduce the ischemic lesion volume but shift the inflammatory response from a M1 to M2 phenotype and promote functional recovery (31). The gene discussed is ADCYAP1; the disease is ischemia.